Green Lab Retreat hike to Royal Arch in Boulder, November 2019. L-R John DeSisto, Senior Professional Research Assistant (PRA)/PhD candidate; Adam Green, MD, Principal Investigator; Hannah Chatwin, PRA; Aaron Knox, PhD, Senior PRA.
Thank you for visiting the website for the Green Laboratory, part of the Morgan Adams Foundation Pediatric Brain Tumor Research Program at the University of Colorado School of Medicine and Children’s Hospital Colorado, on the Anschutz Medical Campus.
The focus of the Green Lab is on addressing unmet needs in childhood brain tumor treatment through translational research approaches.
We investigate novel targets and therapeutic strategies in the treatment of pediatric high-grade glioma (HGG), including diffuse intrinsic pontine glioma (DIPG).
These tumors represent the number one cause of death in childhood cancer and are highly resistant to current treatments.
We use a variety of high-throughput methods, including shRNA screening, drug screening, and next-generation sequencing to identify weaknesses in these tumors.
We then attempt to exploit these weaknesses through cell culture and mouse models, with the goal of bringing the most effective new therapies to rationally-designed early-phase clinical trials.
There are several trials currently open or in development based on work from our lab.
We are also interested in the mechanism of action and pharmacokinetics of therapies.
Public data from published papers can be found here.